Close Menu

NEW YORK – Qiagen and DiaSorin said on Wednesday that they have received US Food and Drug Administration approval for the Liaison QuantiFeron-TB Plus Test, an automated workflow and assay for latent tuberculosis detection.

As a result, the companies have launched the test in the US.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.